Two infants presented with growth failure and were found to have gener
alized osteomalacia (rickets) due to phosphate depletion from prolonge
d administration of an aluminum-containing antacid given for the sympt
oms of colic. One of the infants developed bilateral proptosis due to
craniosynostosis related to the underlying metabolic bone disease. The
chronic use of aluminum-containing antacids in infants has potential
risk for the growing skeleton and is not innocuous. Therefore, antacid
therapy should be used in low doses and very cautiously, with routine
monitoring of serum calcium and phosphorus in children taking medicat
ions which reduce gastrointestinal phosphate absorption.